Risk of Gastrointestinal Adverse Events Associated With Glucagon-Like Peptide-1 Receptor Agonists for Weight Loss | Clinical Pharmacy and Pharmacology | JAMA

This database study examines the association between glucagon-like peptide 1 agonists (eg, semaglutide, liraglutide) used for weight loss and reports of gastroi

Related Keywords

Vancouver ,British Columbia ,Canada ,United Kingdom ,British ,Karen Lasser ,Jodyw Zylke ,Mahyar Etminan ,Kristin Walter ,University Of British Columbia ,Department Of Ophthalmology ,International Classification Of Diseases ,Eye Care Center ,Pharmetrics Plus ,International Classification ,Ninth Revision ,Deputy Editor ,Visual Sciences ,Interest Disclosures ,